poisar

Stock

Alpha Tau Medical Ltd. DRTS

$13.48-0.44%

Overview

DRTS market data

Price History

DRTS price chart

Valuation & Profitability

no valuation data
No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for DRTS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

10 captured
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price TargetBenzinga · Jul 22, 2026, 4:09 PM
Alpha Tau Medical Announces Positive Data In Head And Neck Cancer Treatment Study, Hitting 100% Objective Response Rate Across Nine Evaluable PatientsBenzinga · Jul 21, 2026, 12:34 PM
Alpha Tau Medical Treats First Patient In ADMIRE Study, Clinical Trial Evaluating Intratumoral Alpha DaRT For Immunocompromised Patients With Recurrent Cutaneous Squamous Cell CarcinomaBenzinga · Jul 15, 2026, 12:35 PM
Alpha Tau Medical Announces Success Treatment With Alpha DaRT Of First Glioblastoma Patient In IsraelBenzinga · Jun 23, 2026, 12:40 PM
Alpha Tau Medical Receives FDA Clearance To Proceed With Enrollment Of Final Seven Patients In U.S. REGAIN TrialBenzinga · Jun 11, 2026, 12:33 PM
Barclays Maintains Overweight on Alpha Tau Medical, Raises Price Target to $17Benzinga · Jun 4, 2026, 1:01 PM
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On WednesdayBenzinga · Jun 3, 2026, 3:25 PM
Alpha Tau Medical shares are trading lower. The company announced overall survival and safety results from a pooled analysis of three prospective Phase I/II clinical studies evaluating endoscopic ultrasound-guided intratumoral Alpha DaRT treatment in patients with pancreatic ductal adenocarcinoma.Benzinga · Jun 1, 2026, 3:04 PM
Alpha Tau Medical Presents Overall Survival, Safety Results From Pooled Analysis Of Three Prospective Phase I/II Clinical Studies Evaluating EUS-Guided Intratumoral Alpha Dart Treatment In PDAC Patients At 2026 ASCO Annual MeetingBenzinga · Jun 1, 2026, 1:06 PM
Barclays Initiates Coverage On Alpha Tau Medical with Overweight Rating, Announces Price Target of $15Benzinga · May 28, 2026, 1:35 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock